218 related articles for article (PubMed ID: 20083608)
21. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
Tränkle C; Kostenis E; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.
Zürn A; Zabel U; Vilardaga JP; Schindelin H; Lohse MJ; Hoffmann C
Mol Pharmacol; 2009 Mar; 75(3):534-41. PubMed ID: 19106230
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.
Hernandez CC; Nascimento JH; Chaves EA; Costa PC; Masuda MO; Kurtenbach E; Campos DE Carvalho AC; Gimenez LE
J Recept Signal Transduct Res; 2008; 28(4):375-401. PubMed ID: 18702010
[TBL] [Abstract][Full Text] [Related]
24. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
[TBL] [Abstract][Full Text] [Related]
25. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands.
Huang XP; Ellis J
Mol Pharmacol; 2007 Mar; 71(3):759-68. PubMed ID: 17132687
[TBL] [Abstract][Full Text] [Related]
26. Probing the selectivity of allosteric modulators of muscarinic receptors at other G-protein-coupled receptors.
Pfaffendorf M; Batink HD; Tränkle C; Mohr K; van Zwieten PA
J Auton Pharmacol; 2000 Feb; 20(1):55-62. PubMed ID: 11048962
[TBL] [Abstract][Full Text] [Related]
27. Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M
She X; Pegoli A; Gruber CG; Wifling D; Carpenter J; Hübner H; Chen M; Wan J; Bernhardt G; Gmeiner P; Holliday ND; Keller M
J Med Chem; 2020 Apr; 63(8):4133-4154. PubMed ID: 32233403
[TBL] [Abstract][Full Text] [Related]
28. Utility of an "Allosteric Site-Impaired" M
Moo EV; Sexton PM; Christopoulos A; Valant C
Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
Abdul-Ridha A; López L; Keov P; Thal DM; Mistry SN; Sexton PM; Lane JR; Canals M; Christopoulos A
J Biol Chem; 2014 Feb; 289(9):6067-79. PubMed ID: 24443568
[TBL] [Abstract][Full Text] [Related]
30. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
[TBL] [Abstract][Full Text] [Related]
31. Investigating the interaction of McN-A-343 with the M2 muscarinic receptor using its nitrogen mustard derivative.
Suga H; Ehlert FJ
Biochem Pharmacol; 2010 Apr; 79(7):1025-35. PubMed ID: 19913516
[TBL] [Abstract][Full Text] [Related]
32. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
Prilla S; Schrobang J; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
[TBL] [Abstract][Full Text] [Related]
33. Novel Xanomeline-Containing Bitopic Ligands of Muscarinic Acetylcholine Receptors: Design, Synthesis and FRET Investigation.
Matera C; Kauk M; Cirillo D; Maspero M; Papotto C; Volpato D; Holzgrabe U; De Amici M; Hoffmann C; Dallanoce C
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903650
[TBL] [Abstract][Full Text] [Related]
34. Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors.
Matucci R; Bellucci C; Martino MV; Nesi M; Manetti D; Welzel J; Bartz U; Holze J; Tränkle C; Mohr K; Mazzolari A; Vistoli G; Dei S; Teodori E; Romanelli MN
Eur J Pharmacol; 2020 Sep; 883():173183. PubMed ID: 32534072
[TBL] [Abstract][Full Text] [Related]
35. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria.
Lanzafame A; Christopoulos A; Mitchelson F
Eur J Pharmacol; 2001 Mar; 416(3):235-44. PubMed ID: 11290374
[TBL] [Abstract][Full Text] [Related]
36. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
37. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors.
Tränkle C; Dittmann A; Schulz U; Weyand O; Buller S; Jöhren K; Heller E; Birdsall NJ; Holzgrabe U; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2005 Dec; 68(6):1597-610. PubMed ID: 16157694
[TBL] [Abstract][Full Text] [Related]
38. Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.
Granier S; Kim S; Shafer AM; Ratnala VR; Fung JJ; Zare RN; Kobilka B
J Biol Chem; 2007 May; 282(18):13895-905. PubMed ID: 17347144
[TBL] [Abstract][Full Text] [Related]
39. A model of the human M2 muscarinic acetylcholine receptor.
Jöhren K; Höltje HD
J Comput Aided Mol Des; 2002 Nov; 16(11):795-801. PubMed ID: 12825791
[TBL] [Abstract][Full Text] [Related]
40. A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell.
Azpiazu I; Gautam N
J Biol Chem; 2004 Jun; 279(26):27709-18. PubMed ID: 15078878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
